Cargando…
Decreased Ratio of Treg Cells to Th17 Cells Correlates with HBV DNA Suppression in Chronic Hepatitis B Patients Undergoing Entecavir Treatment
BACKGROUND: Treatment with nucleotide analogs is known to be effective in inhibiting HBV replication; however, patients with chronic hepatitis B (CHB) often show a wide range of clinical responses to these drugs. Therefore, the identification of an early immunologic marker associated with the clinic...
Autores principales: | Zhang, Ji-Yuan, Song, Chun-Hui, Shi, Feng, Zhang, Zheng, Fu, Jun-Liang, Wang, Fu-Sheng |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2975625/ https://www.ncbi.nlm.nih.gov/pubmed/21079784 http://dx.doi.org/10.1371/journal.pone.0013869 |
Ejemplares similares
-
The Ratio of Circulating Regulatory T Cells (Tregs)/Th17 Cells Is Associated with Acute Allograft Rejection in Liver Transplantation
por: Wang, Ying, et al.
Publicado: (2014) -
Tenofovir versus entecavir on decreasing risk of HBV-related hepatocellular carcinoma recurrence after liver transplantation
por: Yang, Jianming, et al.
Publicado: (2023) -
HBV DNA suppression during entecavir treatment in previously treated children with chronic hepatitis B
por: Pawłowska, M., et al.
Publicado: (2011) -
Increased Th17/Treg Ratio in Poststroke Fatigue
por: Liu, Xinjing, et al.
Publicado: (2015) -
Combination therapy of therapeutic antibody and vaccine or entecavir in HBV carrier mice
por: Qi, Ruoyao, et al.
Publicado: (2023)